­
­
­
­

Inventi Impact: Oncology

Articles

  • Inventi:hoc/23998/17
    Immunity Enhancement in Immunocompromised Gastrointestinal Cancer Patients with Allogeneic\nUmbilical Cord Blood Mononuclear Cell Transfusion
    01-Jan-1970 Research 2017 : October - December
    Ying Qiu, Ruidong Zhao, Mark M Yun, Xia Han, Feiyu Yun, Bingchun Liu, Erxia Zhou, Xiaohui Ouyang, Sheng Yun

    Objectives. In order to enhance the immunity of cancer patients to prevent relapse or to prolong survival time, umbilical cord\nblood mononuclear cells (UCMCs) were transplanted to cancer patients. Patients and Methods. UCMCs were transfused to 63\nimmunocompromised gastrointestinal cancer patients with nonmyeloablative (NMA) conditioning regimen. Results.The clinical\nstudy showed that the number of both T and B cells increased much more rapidly after transfusion of UCMCs than that of the\ncontrol group without transplantation (

    How to Cite this Article
    CC Compliant Citation: Ying Qiu, Ruidong Zhao, Mark M. Yun, et\nal., â??Immunity Enhancement in Immunocompromised\nGastrointestinal Cancer Patients with Allogeneic Umbilical Cord\nBlood Mononuclear Cell Transfusion,â? BioMed Research\nInternational, vol. 2017, Article ID 5945190, 8 pages, 2017.\ndoi:10.1155/2017/5945190, http://creativecommons.org/\nlicenses/by/4.0/.
    Download Full Text